What happens when first-line treatment for Multiple Myeloma stops working

When First-Line Treatment Stops Working in Multiple Myeloma

This is an important question, and the good news is that multiple myeloma has many treatment options available when the initial therapy becomes less effective.

What "Stops Working" Means

According to the NCCN Guidelines for Patients: Multiple Myeloma, when your first treatment no longer controls the disease, doctors describe this in specific ways:

• Progression: The cancer doesn't improve or becomes worse while you're on treatment
• Relapse: The cancer comes back after being in remission (when signs and symptoms decreased or disappeared)
• Resistance: The myeloma cells develop the ability to survive the drugs you're taking

Your Treatment Team's Approach

When first-line treatment stops working, your oncologist will:

1. Assess your response - They'll use the same tests that diagnosed your myeloma (blood tests for M proteins, imaging scans, bone marrow biopsies) to confirm the cancer is progressing

2. Review your overall health - Your fitness level, organ function, and how well you tolerated the first treatment all matter for choosing what's next

3. Consider what you've already received - The specific drugs you took first influence which options work best next

Treatment Options for Relapsed or Resistant Myeloma

According to NCCN Guidelines, here are the main pathways:

After 1-2 prior therapies:

• CAR T-cell therapy (Abecma or Carvykti) - This reprograms your own T cells (a type of white blood cell) to recognize and attack myeloma cells more effectively
• Bispecific antibodies (like Tecvayli or Talvey) - These drugs act like a bridge, connecting your T cells directly to myeloma cells so they can destroy them
• New drug combinations - Different targeted therapies, immunomodulators, or monoclonal antibodies than your first treatment

After 3-4 prior therapies:

• CAR T-cell therapy becomes a preferred option
• Bispecific antibodies remain important choices
• Other targeted therapies continue to be available

Why Multiple Options Exist

Multiple myeloma cells can develop resistance to specific drugs, but they typically can't resist all drugs at once. This is why your care team can switch to different medication classes or combinations. The NCCN Guidelines emphasize that "there are many types of treatment available. So if one therapy doesn't work for you, you can try a different one."

Important Questions to Ask Your Oncologist

When your first treatment stops working, ask:

1. What do the test results show specifically? (M protein levels, imaging findings, bone marrow results)
2. Why do you think this treatment stopped working? (Did the cancer become resistant, or did I not tolerate it well?)
3. What are my top 2-3 options for next treatment, and why do you recommend them?
4. Am I a candidate for CAR T-cell therapy or bispecific antibodies? (These are increasingly important options)
5. Are there clinical trials I should consider?
6. How will we monitor whether the new treatment is working?

The Bottom Line

Treatment failure in multiple myeloma is not the end of your options—it's a transition point. According to NCCN Guidelines, "sooner or later, myeloma usually comes back and requires additional treatment," but this is expected and planned for. The field has expanded dramatically, with newer immunotherapies offering responses even after multiple prior treatments.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.